Alto Neuroscience, Stock Market Value
| ANRO Stock | 4.28 0.05 1.15% |
| Symbol | Alto |
Alto Neuroscience, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Alto Neuroscience, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alto Neuroscience,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alto Neuroscience,.
| 06/01/2024 |
| 11/28/2024 |
If you would invest 0.00 in Alto Neuroscience, on June 1, 2024 and sell it all today you would earn a total of 0.00 from holding Alto Neuroscience, or generate 0.0% return on investment in Alto Neuroscience, over 180 days. Alto Neuroscience, is related to or competes with Saia, Allient, Lindblad Expeditions, Old Dominion, Freedom Internet, and BCE. Alto Neuroscience, is entity of United States More
Alto Neuroscience, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alto Neuroscience,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alto Neuroscience, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 84.64 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 7.14 |
Alto Neuroscience, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alto Neuroscience,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alto Neuroscience,'s standard deviation. In reality, there are many statistical measures that can use Alto Neuroscience, historical prices to predict the future Alto Neuroscience,'s volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (1.14) | |||
| Total Risk Alpha | (2.16) | |||
| Treynor Ratio | (0.17) |
Alto Neuroscience, Backtested Returns
Alto Neuroscience, secures Sharpe Ratio (or Efficiency) of -0.0822, which signifies that the company had a -0.0822% return per unit of risk over the last 3 months. Alto Neuroscience, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alto Neuroscience,'s Mean Deviation of 4.69, risk adjusted performance of (0.04), and Standard Deviation of 9.84 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.94, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alto Neuroscience, will likely underperform. At this point, Alto Neuroscience, has a negative expected return of -0.82%. Please make sure to confirm Alto Neuroscience,'s treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Alto Neuroscience, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.51 |
Modest predictability
Alto Neuroscience, has modest predictability. Overlapping area represents the amount of predictability between Alto Neuroscience, time series from 1st of June 2024 to 30th of August 2024 and 30th of August 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alto Neuroscience, price movement. The serial correlation of 0.51 indicates that about 51.0% of current Alto Neuroscience, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 18.8 |
Alto Neuroscience, lagged returns against current returns
Autocorrelation, which is Alto Neuroscience, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alto Neuroscience,'s stock expected returns. We can calculate the autocorrelation of Alto Neuroscience, returns to help us make a trade decision. For example, suppose you find that Alto Neuroscience, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Alto Neuroscience, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alto Neuroscience, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alto Neuroscience, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alto Neuroscience, stock over time.
Current vs Lagged Prices |
| Timeline |
Alto Neuroscience, Lagged Returns
When evaluating Alto Neuroscience,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alto Neuroscience, stock have on its future price. Alto Neuroscience, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alto Neuroscience, autocorrelation shows the relationship between Alto Neuroscience, stock current value and its past values and can show if there is a momentum factor associated with investing in Alto Neuroscience,.
Regressed Prices |
| Timeline |
Pair Trading with Alto Neuroscience,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alto Neuroscience, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will appreciate offsetting losses from the drop in the long position's value.Moving together with Alto Stock
| 0.62 | VALN | Valneva SE ADR | PairCorr |
| 0.66 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.77 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.81 | LLY | Eli Lilly Sell-off Trend | PairCorr |
Moving against Alto Stock
| 0.77 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.76 | GILD | Gilead Sciences | PairCorr |
| 0.68 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.67 | PMVP | Pmv Pharmaceuticals | PairCorr |
| 0.59 | PHVS | Pharvaris BV | PairCorr |
The ability to find closely correlated positions to Alto Neuroscience, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alto Neuroscience, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alto Neuroscience, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alto Neuroscience, to buy it.
The correlation of Alto Neuroscience, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alto Neuroscience, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Alto Neuroscience, Correlation, Alto Neuroscience, Volatility and Alto Neuroscience, Alpha and Beta module to complement your research on Alto Neuroscience,. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Alto Neuroscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.